In their constant search for new ways to stay thin, Hollywood embraced a new fad in 2023 in the form of the injectable type-2 diabetes drug called Ozempic.
and molecular analogs that bind to the same GLP-1 receptors have been around for years.
According to Jens Juul Holst, a medical researcher at the University of Copenhagen in Denmark, there's one massive issue with this class of treatment..Though we can only guess at many of those reasons, Holst explains simple satisfaction is likely to play a big part in going off the medication. Appetite, like sex drive, incentivizes activities that aren't just biologically favorable – they're fun. Robbed of our ability to desire food, we're less inclined to continue treatment, raising the risk of falling back into old habits.
"That may eventually be a problem, that once you've been on this for a year or two, life is so miserably boring that you can't stand it any longer and you have to go back to your old life," HolstThat doesn't mean Wegovy or other approved GLP-1 type drugs can't play a role in losing weight, especially in combination with other therapies and guidance on how to turn healthy eating and physical activity into life-long routines.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
A new pill may work as well as Ozempic and Wegovy shots to treat obesityNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes
Baca lebih lajut »
A daily pill may work as well as Ozempic, Wegovy shots to treat obesity: studyNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs may work as well as injections — even in hard-to-treat people with diabetes.
Baca lebih lajut »
Pfizer scraps one weight loss drug in race to develop Ozempic rivalPfizer Inc said on Monday it will drop the development of experimental obesity and diabetes drug lotiglipron and focus on another treatment, as the drugmaker races to tap the promising market for weight loss drugs.
Baca lebih lajut »
New pill forms of Ozempic, Wegovy a diabetes and weight-loss ‘game-changer’If approved, the new pill forms of semaglutide could revolutionize the fast-changing weight-loss landscape.
Baca lebih lajut »
Yes, ‘Ozempic Butt’ Is a Thing—Here’s How It HappensWhat Is ‘Ozempic Butt’ and Why Does This Side Effect Happen?
Baca lebih lajut »
New Drugs Line Up to Challenge Ozempic, Wegovy for Weight LossAfter drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed.
Baca lebih lajut »